{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:58:39Z","timestamp":1790330319488,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS065838"],"award-info":[{"award-number":["R01NS065838"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC2DA29475"],"award-info":[{"award-number":["RC2DA29475"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000100"],"award-info":[{"award-number":["UL1TR000100"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR00099"],"award-info":[{"award-number":["KL2TR00099"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["EB00790-06"],"award-info":[{"award-number":["EB00790-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Institute Cancer Center Specialized Grant","award":["P30CA023100"],"award-info":[{"award-number":["P30CA023100"]}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation Grant","doi-asserted-by":"crossref","award":["1430082"],"award-info":[{"award-number":["1430082"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["ACS-IRG 70-002"],"award-info":[{"award-number":["ACS-IRG 70-002"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-15-229-01-CCE"],"award-info":[{"award-number":["RSG-15-229-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11060-017-2613-7","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T06:02:54Z","timestamp":1504504974000},"page":"601-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Imaging correlates for the 2016 update on WHO classification of grade II\/III gliomas: implications for IDH, 1p\/19q and ATRX status"],"prefix":"10.1007","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2373-5419","authenticated-orcid":false,"given":"Rachel L.","family":"Delfanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Handwerker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeim","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnithaPriya","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Karunamuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jona A.","family":"Hattangadi-Gluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler M.","family":"Seibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Srikant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karra A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian S.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders M.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan S.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie R.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikdokht","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"The Cancer Genome Atlas Research Network","year":"2015","unstructured":"The Cancer Genome Atlas Research Network (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498","journal-title":"N Engl J Med"},{"key":"2613_CR2","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W","volume":"79","author":"SW Coons","year":"1997","unstructured":"Coons SW, Johnson PC, Scheithauer BW et al (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381\u20131393","journal-title":"Cancer"},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","volume":"120","author":"MJ Van den Bent","year":"2010","unstructured":"Van den Bent MJ (2010) Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician\u2019s perspective. Acta Neuropathol 120:297\u2013304","journal-title":"Acta Neuropathol"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM et al (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499\u20132508","journal-title":"N Engl J Med"},{"key":"2613_CR5","first-page":"1175","volume":"145","author":"J Reifenberger","year":"1994","unstructured":"Reifenberger J, Reifenberger G, Liu L et al (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175\u20131190","journal-title":"Am J Pathol"},{"key":"2613_CR6","doi-asserted-by":"publisher","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","volume":"66","author":"RB Jenkins","year":"2006","unstructured":"Jenkins RB, Blair H, Ballman KV et al (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852\u20139861","journal-title":"Cancer Res"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","volume":"31","author":"G Cairncross","year":"2013","unstructured":"Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337\u2013343","journal-title":"J Clin Oncol"},{"key":"2613_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","volume":"31","author":"MJ Van den Bent","year":"2013","unstructured":"Van den Bent MJ, Brandes AA, Taphoorn MJ et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344\u2013350","journal-title":"J Clin Oncol"},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","volume":"27","author":"M Sanson","year":"2009","unstructured":"Sanson M, Marie Y, Paris S et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150\u20134154","journal-title":"J Clin Oncol"},{"key":"2613_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","volume":"174","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Nobusawa S, Kleihues P et al (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149\u20131153","journal-title":"Am J Pathol"},{"key":"2613_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","volume":"118","author":"C Hartmann","year":"2009","unstructured":"Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118:469\u2013474","journal-title":"Acta Neuropathol"},{"key":"2613_CR13","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1101\/gr.132738.111","volume":"22","author":"CG Duncan","year":"2012","unstructured":"Duncan CG, Barwick BG, Jin G et al (2012) A heterozygous IDH1R132H\/WT mutation induces genome-wide alterations in DNA methylation. Genome Res 22:2339\u20132355","journal-title":"Genome Res"},{"key":"2613_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr H, Weisenberger DJ, Diefes K et al (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510\u2013522","journal-title":"Cancer Cell"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-012-1031-3","volume":"124","author":"XY Liu","year":"2012","unstructured":"Liu XY, Gerges N, Korshunov A et al (2012) Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1\/IDH2 and TP53 mutations. Acta Neuropathol 124:615\u2013625","journal-title":"Acta Neuropathol"},{"key":"2613_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1200\/JCO.2013.49.3726","volume":"32","author":"JG Cairncross","year":"2014","unstructured":"Cairncross JG, Wang M, Jenkins RB et al (2014) Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol 32:783\u2013790","journal-title":"J Clin Oncol"},{"key":"2613_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.18632\/oncotarget.689","volume":"3","author":"K Kannan","year":"2012","unstructured":"Kannan K, Inagaki A, Silber J et al (2012) Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma. Oncotarget 3:1194\u20131203","journal-title":"Oncotarget"},{"key":"2613_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00401-013-1156-z","volume":"126","author":"B Wiestler","year":"2013","unstructured":"Wiestler B, Capper D, Holland-Letz T et al (2013) ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. Acta Neuropathol 126:443\u2013451","journal-title":"Acta Neuropathol"},{"key":"2613_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"2613_CR20","volume-title":"WHO classification of tumors of the central nervous system","author":"DN Louis","year":"2016","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) WHO classification of tumors of the central nervous system. IARC, Lyon"},{"key":"2613_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/bpa.12171","volume":"24","author":"DN Louis","year":"2014","unstructured":"Louis DN, Perry A, Burger P et al (2014) International society of Neuropathology-haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429\u2013435","journal-title":"Brain Pathol"},{"key":"2613_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/neuonc\/nov182","volume":"18","author":"HJ Dubbink","year":"2016","unstructured":"Dubbink HJ, Atmodimedjo PN, Kros JM et al (2016) Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro Oncol 18:388\u2013400","journal-title":"Neuro Oncol"},{"key":"2613_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00401-010-0777-8","volume":"120","author":"P Metellus","year":"2010","unstructured":"Metellus P, Coulibaly B, Colin C et al (2010) Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol 120:719\u2013729","journal-title":"Acta Neuropathol"},{"key":"2613_CR24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3892\/ol.2014.2013","volume":"7","author":"S Qi","year":"2014","unstructured":"Qi S, Yu L, Li H et al (2014) Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett 7:1895\u20131902","journal-title":"Oncol Lett"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/jmv.24413","volume":"5","author":"AJ da Fonseca","year":"2016","unstructured":"da Fonseca AJ, Galv\u00e3o RS, Miranda AE et al (2016) Comparison of three human papillomavirus DNA detection methods: next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing. J Med Virol 5:888\u2013894","journal-title":"J Med Virol"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/brain\/awl108","volume":"129","author":"MD Jenkinson","year":"2006","unstructured":"Jenkinson MD, du Plessis DG, Smith TS et al (2006) Histological growth patterns and genotype in oligodendroglial tumors: correlation with MRI features. Brain 129:1884\u20131891","journal-title":"Brain"},{"key":"2613_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/neuonc\/not235","volume":"16","author":"G Reyes-Botero","year":"2014","unstructured":"Reyes-Botero G, Caroline D, Idbaih A et al (2014) Contrast enhancement in 1p\/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability and angiogenic gene expression. Neuro Oncol. 16:662\u2013670","journal-title":"Neuro Oncol."},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1200\/JCO.2010.33.8715","volume":"29","author":"A Lai","year":"2011","unstructured":"Lai A, Kharbanda S, Pope WB et al (2011) Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29:4482\u20134490","journal-title":"J Clin Oncol"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccr.2010.10.033","volume":"18","author":"AI Persson","year":"2010","unstructured":"Persson AI, Petritsch C, Swartling FJ et al (2010) Non-stem cell origin for oligodendroglioma. Cancer Cell 18:669\u2013682","journal-title":"Cancer Cell"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"30295","DOI":"10.18632\/oncotarget.4497","volume":"6","author":"HE Leeper","year":"2015","unstructured":"Leeper HE, Caron AA, Decker PA et al (2015) IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Oncotarget 6:30295\u201330305","journal-title":"Oncotarget"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00401-015-1438-8","volume":"129","author":"DE Reuss","year":"2015","unstructured":"Reuss DE, Mamatjan Y, Schrimpf D et al (2015) IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathol 129:867\u2013873","journal-title":"Acta Neuropathol"},{"key":"2613_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00401-015-1398-z","volume":"129","author":"A Olar","year":"2015","unstructured":"Olar A, Wani KM, Alfaro-Munoz KD et al (2015) IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II\u2013III diffuse gliomas. Acta Neuropathol 129:585\u2013596","journal-title":"Acta Neuropathol"},{"key":"2613_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","volume":"47","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458\u2013466","journal-title":"Nat Genet"}],"updated-by":[{"DOI":"10.1007\/s11060-017-2620-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T00:00:00Z","timestamp":1505260800000}}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2613-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2613-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2613-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:28:29Z","timestamp":1589700509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2613-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2613-7","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s11060-017-2620-8","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]},"assertion":[{"value":"19 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the initial online publication, the values in the last two rows in Table\u00a01 were in the wrong rows. The original article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}